Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Topical PUVA and tacrolimus ointment can effectively and safely treat infant alopecia universalis.

The study created a new method to test drugs that affect hormone processing in skin.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Early regulatory T cells are crucial for normal skin pigmentation.

Retinoic acid-binding proteins in skin are regulated by β-catenin and Notch signalling.

RAR-gamma 1 is important for normal skin maintenance and differentiation.

Minoxidil and ATRA together boost hair growth more effectively than minoxidil alone.

The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.

Vitamin A helps skin stem cells decide their function, aiding in hair growth and wound repair.

Alitretinoin can effectively treat frontal fibrosing alopecia.

Putting calcipotriol ointment on the skin once doesn't change calcium levels in the body right away.

Isotretinoin shrinks sebaceous glands without affecting hair or skin color, unlike etretinate.

Vitamin D3 is a safe and effective alternative to steroids for treating alopecia areata, with fewer side effects.

Human hair follicles can be used to create skin-like tissue for wound healing and drug testing.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Alitretinoin may help treat alopecia areata.

Acitretin effectively improved the woman's skin condition.

Hydrocortisone ointment effectively improved eyebrow skin and hair in a 10-year-old.

Encapsulating ascorbyl palmitate in curcumin-grafted particles improves its stability and skin penetration.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

The correction does not change the study's main findings.

The combination therapy was effective and well-tolerated, especially in young patients.

Travoprost can help eyelash growth but may cause darkening around the eyes.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Topical tacrolimus is effective and safe for treating alopecia areata.